The introduction of Semaglutide at a higher strength represents a notable step forward in addressing type 2 diabetes. Before, reduced doses were typically administered, but this new formulation offers the chance for greater blood sugar control in certain patients. Doctors are assessing its impact and security profile, especially in patients who … Read More